[PDF] Top 20 LGL leukemia: from pathogenesis to treatment
Has 10000 "LGL leukemia: from pathogenesis to treatment" found on our website. Below are the top 20 most common "LGL leukemia: from pathogenesis to treatment".
LGL leukemia: from pathogenesis to treatment
... LGL leukemia principally affects elderly people with a median age of 60 years 13,7,8,56,57,58,59 ...related to neutropenia and includes recurrent oral aphthous ulcerations, fever secondary to ... Voir le document complet
41
Long-term dyadic adjustment of parents of children with acute lymphoblastic leukemia : couples’ experiences from treatment completion to survivorship
... According to the Canadian Cancer Society (2017), 32% of all new cases of childhood cancer in Canada are leukemia, thus signifying the largest incidence of all childhood cancer ...types. Leukemia can ... Voir le document complet
187
View of Specific pulmonary involvement in acute myeloid leukemia: from diagnosis to treatment
... Dans une étude rétrospective portant sur 20 patients atteints de LAM5 et admis en réanimation pour une IRA secondaire à une leucostase pulmonaire ou une infiltration pulmonaire leu- cémi[r] ... Voir le document complet
8
Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients
... pathway, from the early stages of cancer development to survival [ 1 – 5 ...access to treatment have been pointed out as the most important ex- planatory factors of social inequalities in ... Voir le document complet
13
Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia.
... tributed to the development of t-MN with 11q23/MLL rearrange- ...blast from those patients who subsequently developed SMNs, including t-MN, could also reflect inherited genetic variants 38 that could influ- ... Voir le document complet
11
Impact of gene mutations on treatment response and prognosis of acute myeloid leukemia secondary to myeloproliferative neoplasms
... like 3+7 are used in eligible patients but the response rate is low, toxicity and mortality high with poor long term results 5 . Encouraging results have been obtained with hypomethylating agents but data are still ... Voir le document complet
30
A Canadian perspective on severe acute respiratory syndrome coronavirus 2 infection and treatment: how prevalent underlying inflammatory disease contributes to pathogenesis
... –CoV-2 to the ACE2 receptor expressing cells in the airway that is more abundantly expressed by type II pneumocytes and to a lower extent by type I pneumocytes, alveolar epithelial cells and pulmonary ... Voir le document complet
23
A Canadian perspective on severe acute respiratory syndrome coronavirus 2 infection and treatment: how prevalent underlying inflammatory disease contributes to pathogenesis
... the pathogenesis of SARS-CoV-2, as high levels of IL-17 were shown to be highly positively correlated with disease severity (Pacha et ...released from the neutrophils that entrap and kill pathogens ... Voir le document complet
76
Killer immunoglobulin‐like receptor genotypes and chronic myeloid leukemia outcomes after imatinib cessation for treatment‐free remission
... grant from the SIRIC BRIO (B2BB ...program from the University Hospital of Bordeaux for two ...decision to pub- lish or preparation of the ... Voir le document complet
11
Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia
... used to detect remaining tumor cells when assessing the response to ...used to demonstrate the absence of a genetic aberration detected at ...rable to that of morphology and immunophenotyping ... Voir le document complet
12
Plasma proteomic approach in patients with heart failure: insights into pathogenesis of disease progression and potential novel treatment targets.
... grants from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Cytokinetics, GSK, Myokardia, Novartis, Roche Diag- notics and ...grants from Vifor and Abbott Vascular, and fees for consultancy from ... Voir le document complet
12
Eosinophilic oesophagitis: From physiopathology to treatment.
... Two to four biopsies should be performed both in the distal and in the proximal ...threshold to diagnose eosinophilic ...impact to orient treatment remains to be ...esophagitis ... Voir le document complet
27
Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571.
... acute leukemia in first relapse underwent an allogene- ic CD34-selected ...transplant from an unrelated male donor after a conditioning regimen consisting in 12 Gy total body irradiation, Ara-C (18 g/m 2 ) ... Voir le document complet
2
Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: Recommendations for clinical practice from the French Chronic Myeloid Leukemia Study Group
... Myeloid Leukemia Study Group BACKGROUND: The ultimate goal of chronic myeloid leukemia management in the tyrosine kinase inhibitor (TKI) era for patients who obtain deep molecular responses is maintaining a ... Voir le document complet
8
Cyclophosphamide as a first-line therapy in LGL leukemia
... for LGL leukemia from 1989 to 2012 were retro- spectively included in this ...50 to 75 mg/day (n ¼ 8) taken orally and 1 g IV/month (n ¼ ...time from diagnosis to ... Voir le document complet
4
Genetic predisposition to corticosteroid : related complications of childhood Acute Lymphoblastic Leukemia (cALL) treatment
... extended to target functional non-protein-coding elements, like microRNA, long intergenic noncoding RNA, as well as specific candidate loci [57, ...used to selectively hybridize to target regions in ... Voir le document complet
85
Lipodystrophic syndromes: From diagnosis to treatment
... lead to episodes of acute pancreatitis, is common in insulin resistance states owing to abnormalities of insulin pathway signaling downstream of the insulin receptor, as is the case in lipodystrophic ... Voir le document complet
21
Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France
... Conclusions To conclude, the present results confirm that not all injecting drug users would be interested in IV buprenor- phine ...appear to be the most suitable populations to propose this ... Voir le document complet
12
Acid mediated chemical treatment to remove sugar from waste acid stream from nano-crystalline cellulose manufacturing process.
... time from 2 h to 1 h. Apart from process time reduction, the heating method has offered additional improvements ...respect to sample: acid ratio, sugar removal achieved a maximum at ...similar ... Voir le document complet
29
Spinal Motoneuron TMEM16F Acts at C-boutons to Modulate Motor Resistance and Contributes to ALS Pathogenesis
... Contributes to Ca 2+ -Activated Cl Conductance in Spinal Motoneurons To characterize the molecular identity of CaCCs, we determined expression levels of the 10 Tmem16 family members and the 3 Bestrophin ... Voir le document complet
22
Sujets connexes